Compare · MDLN vs NURO
MDLN vs NURO
Side-by-side comparison of Medline Inc. (MDLN) and NeuroMetrix Inc. (NURO): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both MDLN and NURO operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
- MDLN carries a market cap of $48.72B.
- MDLN has hit the wire 24 times in the past 4 weeks while NURO has been quiet.
- MDLN has more recent analyst coverage (25 ratings vs 0 for NURO).
- Company
- Medline Inc.
- NeuroMetrix Inc.
- Price
- -
- -
- Market cap
- $48.72B
- -
- 1M return
- +6.28%
- -
- 1Y return
- -9.03%
- -
- Industry
- Medical/Dental Instruments
- Medical/Dental Instruments
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2025
- 2004
- News (4w)
- 24
- 0
- Recent ratings
- 25
- 0
NeuroMetrix Inc.
NeuroMetrix, Inc., a healthcare company, develops and markets products for the detection, diagnosis, and monitoring of peripheral nerve and spinal cord disorders. The company develops wearable neuro-stimulation therapeutic devices and point-of-care neuropathy diagnostic tests to address chronic health conditions, including chronic pain, sleep disorders, and diabetes. Its marketed products include Quell, a wearable device for relief of chronic intractable pain, such as nerve pain due to diabetes and lower back problems; DPNCheck, a test used to evaluate systemic neuropathies, such as diabetic peripheral neuropathy; ADVANCE system, a platform for the performance of traditional nerve conduction studies; and SENSUS, a pain therapy device based on transcutaneous electrical nerve stimulation for relief of chronic intractable pain. The company offers its products to consumers, retail merchandisers, direct response TV promoters, health care professionals, managed care organizations, endocrinologists, podiatrists, physicians, neurologists, and physical medicine and rehabilitation centers, as well as primary care, internal medicine, orthopedic, hand, and neurosurgeons. It operates in the United States, Europe, Japan, China, the Middle East, and Mexico. The company has a strategic collaboration with GlaxoSmithKline. NeuroMetrix, Inc. was founded in 1996 and is based in Woburn, Massachusetts.
Latest MDLN
- Large owner Cp Circle Ml Holdco Gp, Llc converted options into 3,709,698 shares and disposed of 3,709,698 units of Class B Common Stock (SEC Form 4)
- Large owner Carlyle Mozart Coinvestment Holdings, L.P. converted options into 3,709,698 shares and disposed of 3,709,698 units of Class B Common Stock (SEC Form 4)
- Large owner Bx Mozart Ml-1 Holdco L.P. converted options into 7,570,214 shares and disposed of 7,570,214 units of Class B Common Stock (SEC Form 4)
- Large owner Tc Group Cayman Investment Holdings, L.P. converted options into 3,709,698 shares and disposed of 3,709,698 units of Class B Common Stock (SEC Form 4)
- Large owner Carlyle Group Inc. converted options into 3,709,698 shares and disposed of 3,709,698 units of Class B Common Stock (SEC Form 4)
- Large owner Hellman & Friedman Capital Partners X (Parallel), L.P. converted options into 12,128,729 shares and disposed of 12,128,729 units of Class B Common Stock (SEC Form 4)
- Large owner Bcp 8 Holdings Mozart Manager L.L.C. converted options into 7,570,214 shares and disposed of 7,570,214 units of Class B Common Stock (SEC Form 4)
- SEC Form 424B4 filed by Medline Inc.
- Medline Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits
- Medline launches right-sized Ranpak packaging solutions in two key distribution centers
Latest NURO
- SEC Form 15-12G filed by NeuroMetrix Inc.
- SEC Form EFFECT filed by NeuroMetrix Inc.
- SEC Form EFFECT filed by NeuroMetrix Inc.
- SEC Form EFFECT filed by NeuroMetrix Inc.
- SEC Form EFFECT filed by NeuroMetrix Inc.
- SEC Form EFFECT filed by NeuroMetrix Inc.
- SEC Form EFFECT filed by NeuroMetrix Inc.
- SEC Form EFFECT filed by NeuroMetrix Inc.
- SEC Form EFFECT filed by NeuroMetrix Inc.
- SEC Form EFFECT filed by NeuroMetrix Inc.